An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for definitions; and providing for medical marijuana exemption.

SB 1274 amends Pennsylvania's Controlled Substance Act to update legal definitions regarding hemp and hemp-derived products. The bill clarifies what constitutes "hemp" by setting a THC concentration limit of 0.3% and distinguishes between final consumer products and intermediate manufacturing materials. It also provides specific definitions for terms like "final hemp-derived cannabinoid product" and "industrial hemp" to ensure clarity in regulations. These changes aim to align state law with federal standards while maintaining exemptions for existing medical marijuana programs.